Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2).

Autor: Amina, Belhadj¹ (AUTHOR), Lynda, Addou² (AUTHOR), Sonia, Seddiki¹ (AUTHOR), Adel, Belhadj³ (AUTHOR), Jelloul, Benammar⁴ (AUTHOR), Miloud, Medjamia⁵ (AUTHOR), Tewfik, Sahraoui¹ (AUTHOR), Lynda, Addou Klouche⁶ (AUTHOR), Jelloul, Benammar H⁷ (AUTHOR)

Publikováno v: Indian Journal of Pathology & Microbiology. Apr-Jun2021, Vol. 64 Issue 2, p254-260. 7p.

Contribution To the Evaluation of The Antimicrobial Activity of Essential Oils Extracted from Mentha Pulegium and Laurus Nobilis

Autor: Zouaouia Chama, Nawel Benchiha, Amina Benabbou, Refka Ouramdane, Hadria Derras, Salima Sadek, Lynda Addou-Klouche

Publikováno v: Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology. 15:35-47

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61d4487c795bda9f5d98f5961c060d8a
https://doi.org/10.21608/eajbsc.2023.281334

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.

Autor: Stéphanie Cornen, Arnaud Guille, José Adélaïde, Lynda Addou-Klouche, Pascal Finetti, Marie-Rose Saade, Marwa Manai, Nadine Carbuccia, Ismahane Bekhouche, Anne Letessier, Stéphane Raynaud, Emmanuelle Charafe-Jauffret, Jocelyne Jacquemier, Salvatore Spicuglia, Hugues de The, Patrice Viens, François Bertucci, Daniel Birnbaum, Max Chaffanet

Publikováno v: PLoS ONE, Vol 9, Iss 1, p e81843 (2014)

Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA

Externí odkaz: https://doaj.org/article/dd7de6bb6d7f4633bb855660fd9edec5

Phenotypic functional activities of monocyte change during crosstalk with breast cancer cell and enhancing effect of metformin of IFN-γ-associated antitumor cytokine production

Autor: Lynda Addou-Klouche, Aida Messaoud, Mostefaoui M, Ned J.C. Lamb, Sara Dahou, Wafa Nouari, Mourad Aribi, Gizard F, Anne Fernandez, Miliani M, Benaissti Mi, Gérard Lefranc, Terbeche H, Zoheir Dahmani, Djebri Nc

BackgroundImmune activities of monocytes (MOs) can be altered within the microenvironment of solid malignancies, including breast cancer. Metformin (1,1-dimethylbiguanide hydrochloride, MET), has been shown to decrease tumor cell proliferation, but i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5119ea444563749fd05028f8eca1b8a
https://doi.org/10.1101/2020.02.14.949412

Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity

Autor: Sara Dahou, Florence Gizard, Lynda Addou-Klouche, Anne Fernandez, Mourad Aribi, Wafa Nouari, Nihel Chahinez Djebri, Hadjer Terbeche, Meriem Mostefaoui, Gérard Lefranc, Zoheir Dahmani, Ned Jeremy Charles Lamb, Marwa Miliani, Aida Messaoud, Mahmoud Idris Benaissti

Publikováno v: PLoS ONE, Vol 15, Iss 10, p e0240982 (2020)
PLoS ONE
PLoS ONE, Public Library of Science, 2020, 15 (10), pp.e0240982. ⟨10.1371/journal.pone.0240982⟩

BackgroundImmune activities of monocytes (MOs) can be altered within the microenvironment of solid malignancies, including breast cancer. Metformin (1,1-dimethylbiguanide hydrochloride, MET), has been shown to decrease tumor cell proliferation, but i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b0859da31e1ef354a6c9022c311b46
https://doi.org/10.1371/journal.pone.0240982